Literature DB >> 24432219

Saccharomyces cerevisiae boulardii transient fungemia after intravenous self-inoculation.

Lola Cohen1, Stéphane Ranque2, Didier Raoult3.   

Abstract

We report the case of a young psychotic intravenous drug user injecting herself with Saccharomyces cervisiae (boulardii). She experienced a 24 h fever, resolving spontaneously confirming, quasi experimentally, the inocuity of this yeast in a non-immunocompromised host.

Entities:  

Keywords:  Fungemia; Saccharomyces cerevisiae boulardii; Self-inoculation

Year:  2013        PMID： 24432219      PMCID： PMC3885949          DOI： 10.1016/j.mmcr.2013.02.003

Source DB:  PubMed          Journal:  Med Mycol Case Rep        ISSN： 2211-7539


  3 in total

Review 1.  Saccharomyces cerevisiae fungemia: an emerging infectious disease.

Authors:  Patricia Muñoz; Emilio Bouza; Manuel Cuenca-Estrella; Jose María Eiros; María Jesús Pérez; Mar Sánchez-Somolinos; Cristina Rincón; Javier Hortal; Teresa Peláez
Journal:  Clin Infect Dis       Date:  2005-04-25       Impact factor: 9.079

2.  Evaluation of four pretreatment procedures for MALDI-TOF MS yeast identification in the routine clinical laboratory.

Authors:  Carole Cassagne; Anne-Laure Cella; Pierre Suchon; Anne-Cecile Normand; Stephane Ranque; Renaud Piarroux
Journal:  Med Mycol       Date:  2012-09-16       Impact factor: 4.076

3.  Self-inflicted bacteraemia and fungaemia in Vietnamese migrants.

Authors:  K S Fung; O Scheel; D J Lyon; A F Cheng; J Bendeck
Journal:  Scand J Infect Dis       Date:  1996
  3 in total
  3 in total

1.  Experience with Saccharomyces boulardii Probiotic in Oncohaematological Patients.

Authors:  Beata Sulik-Tyszka; Emilian Snarski; Magda Niedźwiedzka; Małgorzata Augustyniak; Thorvald Nilsen Myhre; Anna Kacprzyk; Ewa Swoboda-Kopeć; Marta Roszkowska; Jadwiga Dwilewicz-Trojaczek; Wiesław Wiktor Jędrzejczak; Marta Wróblewska
Journal:  Probiotics Antimicrob Proteins       Date:  2018-06       Impact factor: 4.609

2.  Saccharomyces cerevisiae fungemia in a critically ill patient with acute cholangitis and long term probiotic use.

Authors:  Mustafa Fadhel; Swapnil Patel; Edward Liu; Michael Levitt; Arif Asif
Journal:  Med Mycol Case Rep       Date:  2018-11-12

Review 3.  The role and influence of gut microbiota in pathogenesis and management of obesity and metabolic syndrome.

Authors:  Parth J Parekh; Eli Arusi; Aaron I Vinik; David A Johnson
Journal:  Front Endocrinol (Lausanne)       Date:  2014-04-07       Impact factor: 5.555
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.